Hundreds of MSU professors, GEU call to remove VP of research Stephen Hsu
By Wendy Guzman,
The State News
| 06. 15. 2020
The accusations tie back to Hsu’s outspoken advocacy for eugenics, or discouraging reproduction from those with genetic defects and disabilities with the intent of improving the quality of the human species.
The Michigan State University Graduate Employees Union and its coalition partners in the STEM community are calling for MSU to remove Senior Vice President for Research and Innovation Stephen Hsu in a Twitter thread denouncing scientific racism, sexism, eugenicist research and conflicts of interest.
As of 9:00 a.m. Monday, a general petition has about 370 signatures and a separate petition of Michigan State professors has about 300 signatures.
Hsu was hired to lead the university's research enterprise, administering faculty and student research across the university as the Vice President for Research and Graduate Studies under ex-MSU President Lou Anna K. Simon in 2012.
Scientific racism and sexism
Scientific racism is the belief that pseudoscientific evidence can support or justify racism, racial inferiority or racial superiority. The GEU compared Hsu's views to white supremacist Stefan Molyneux, including clips from a podcast between Hsu and Molyneux to support these claims.
"A video from a 2017 podcast interview with Senior Vice President for Research and Innovation Stephen Hsu has offended many people," MSU President Samuel L. Stanley said in a statement. "Regardless...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
